Logo image of 3E2.DE

ETSY INC (3E2.DE) Stock Fundamental Analysis

FRA:3E2 - Deutsche Boerse Ag - US29786A1060 - Common Stock - Currency: EUR

42.605  -3.34 (-7.26%)

Fundamental Rating

6

Overall 3E2 gets a fundamental rating of 6 out of 10. We evaluated 3E2 against 15 industry peers in the Broadline Retail industry. 3E2 has an excellent profitability rating, but there are some minor concerns on its financial health. 3E2 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year 3E2 was profitable.
3E2 had a positive operating cash flow in the past year.
Of the past 5 years 3E2 4 years were profitable.
In the past 5 years 3E2 always reported a positive cash flow from operatings.
3E2.DE Yearly Net Income VS EBIT VS OCF VS FCF3E2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

With an excellent Return On Assets value of 12.54%, 3E2 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
3E2's Return On Invested Capital of 16.02% is amongst the best of the industry. 3E2 outperforms 92.86% of its industry peers.
3E2 had an Average Return On Invested Capital over the past 3 years of 14.75%. This is above the industry average of 9.93%.
The 3 year average ROIC (14.75%) for 3E2 is below the current ROIC(16.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.54%
ROE N/A
ROIC 16.02%
ROA(3y)-0.78%
ROA(5y)5.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.75%
ROIC(5y)14.2%
3E2.DE Yearly ROA, ROE, ROIC3E2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

3E2 has a better Profit Margin (10.80%) than 64.29% of its industry peers.
3E2's Profit Margin has declined in the last couple of years.
3E2's Operating Margin of 13.54% is amongst the best of the industry. 3E2 outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of 3E2 has grown nicely.
3E2 has a Gross Margin of 72.42%. This is amongst the best in the industry. 3E2 outperforms 100.00% of its industry peers.
3E2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.54%
PM (TTM) 10.8%
GM 72.42%
OM growth 3Y-12.19%
OM growth 5Y4.53%
PM growth 3Y-20.12%
PM growth 5Y-1.62%
GM growth 3Y0.24%
GM growth 5Y1.61%
3E2.DE Yearly Profit, Operating, Gross Margins3E2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

3E2 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
3E2 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for 3E2 has been reduced compared to 5 years ago.
3E2 has a worse debt/assets ratio than last year.
3E2.DE Yearly Shares Outstanding3E2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
3E2.DE Yearly Total Debt VS Total Assets3E2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

3E2 has an Altman-Z score of 1.91. This is not the best score and indicates that 3E2 is in the grey zone with still only limited risk for bankruptcy at the moment.
3E2's Altman-Z score of 1.91 is on the low side compared to the rest of the industry. 3E2 is outperformed by 71.43% of its industry peers.
The Debt to FCF ratio of 3E2 is 3.37, which is a good value as it means it would take 3E2, 3.37 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 3E2 (3.37) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.37
Altman-Z 1.91
ROIC/WACC1.83
WACC8.74%
3E2.DE Yearly LT Debt VS Equity VS FCF3E2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

3E2 has a Current Ratio of 2.00. This is a normal value and indicates that 3E2 is financially healthy and should not expect problems in meeting its short term obligations.
3E2 has a Current ratio of 2.00. This is in the better half of the industry: 3E2 outperforms 78.57% of its industry peers.
A Quick Ratio of 2.00 indicates that 3E2 should not have too much problems paying its short term obligations.
3E2's Quick ratio of 2.00 is fine compared to the rest of the industry. 3E2 outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
3E2.DE Yearly Current Assets VS Current Liabilites3E2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.33% over the past year.
Measured over the past years, 3E2 shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.54% on average per year.
The Revenue has been growing slightly by 2.18% in the past year.
3E2 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.97% yearly.
EPS 1Y (TTM)5.33%
EPS 3Y-11.42%
EPS 5Y25.54%
EPS Q2Q%66.13%
Revenue 1Y (TTM)2.18%
Revenue growth 3Y6.44%
Revenue growth 5Y27.97%
Sales Q2Q%1.17%

3.2 Future

Based on estimates for the next years, 3E2 will show a very strong growth in Earnings Per Share. The EPS will grow by 35.11% on average per year.
The Revenue is expected to grow by 6.82% on average over the next years.
EPS Next Y10.42%
EPS Next 2Y12.22%
EPS Next 3Y37.19%
EPS Next 5Y35.11%
Revenue Next Year-0.17%
Revenue Next 2Y1.76%
Revenue Next 3Y2.93%
Revenue Next 5Y6.82%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
3E2.DE Yearly Revenue VS Estimates3E2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
3E2.DE Yearly EPS VS Estimates3E2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 10

5

4. Valuation

4.1 Price/Earnings Ratio

3E2 is valuated rather expensively with a Price/Earnings ratio of 19.54.
3E2's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 29.35. 3E2 is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.68 indicates a rather expensive valuation of 3E2.
3E2's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. 3E2 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.54
Fwd PE 17.68
3E2.DE Price Earnings VS Forward Price Earnings3E2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 3E2 is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, 3E2 is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.99
EV/EBITDA 12.44
3E2.DE Per share data3E2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
3E2 has an outstanding profitability rating, which may justify a higher PE ratio.
3E2's earnings are expected to grow with 37.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.88
PEG (5Y)0.77
EPS Next 2Y12.22%
EPS Next 3Y37.19%

0

5. Dividend

5.1 Amount

3E2 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ETSY INC

FRA:3E2 (3/7/2025, 7:00:00 PM)

42.605

-3.34 (-7.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)04-29 2025-04-29/amc
Inst Owners112.17%
Inst Owner ChangeN/A
Ins Owners0.9%
Ins Owner ChangeN/A
Market Cap4.56B
Analysts68
Price Target56.5 (32.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.16%
Min EPS beat(2)-16.48%
Max EPS beat(2)8.16%
EPS beat(4)1
Avg EPS beat(4)-5.47%
Min EPS beat(4)-16.48%
Max EPS beat(4)8.16%
EPS beat(8)3
Avg EPS beat(8)-2.18%
EPS beat(12)4
Avg EPS beat(12)-176.2%
EPS beat(16)8
Avg EPS beat(16)-127.99%
Revenue beat(2)0
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)-0.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.88%
Revenue beat(12)5
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)-6.82%
PT rev (3m)-4.99%
EPS NQ rev (1m)-2.6%
EPS NQ rev (3m)-2.4%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-2.44%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)-2.55%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE 19.54
Fwd PE 17.68
P/S 1.76
P/FCF 6.99
P/OCF 6.58
P/B N/A
P/tB N/A
EV/EBITDA 12.44
EPS(TTM)2.18
EY5.12%
EPS(NY)2.41
Fwd EY5.66%
FCF(TTM)6.1
FCFY14.31%
OCF(TTM)6.47
OCFY15.19%
SpS24.16
BVpS-6.53
TBVpS-11.27
PEG (NY)1.88
PEG (5Y)0.77
Profitability
Industry RankSector Rank
ROA 12.54%
ROE N/A
ROCE 21.69%
ROIC 16.02%
ROICexc 39.36%
ROICexgc 173.09%
OM 13.54%
PM (TTM) 10.8%
GM 72.42%
FCFM 25.25%
ROA(3y)-0.78%
ROA(5y)5.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.75%
ROIC(5y)14.2%
ROICexc(3y)35.74%
ROICexc(5y)46.84%
ROICexgc(3y)158.04%
ROICexgc(5y)N/A
ROCE(3y)19.98%
ROCE(5y)19.24%
ROICexcg growth 3Y8.44%
ROICexcg growth 5Y39.3%
ROICexc growth 3Y36.7%
ROICexc growth 5Y26.36%
OM growth 3Y-12.19%
OM growth 5Y4.53%
PM growth 3Y-20.12%
PM growth 5Y-1.62%
GM growth 3Y0.24%
GM growth 5Y1.61%
F-Score7
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.37
Debt/EBITDA 4.88
Cap/Depr 40.25%
Cap/Sales 1.55%
Interest Coverage 42
Cash Conversion 154.1%
Profit Quality 233.77%
Current Ratio 2
Quick Ratio 2
Altman-Z 1.91
F-Score7
WACC8.74%
ROIC/WACC1.83
Cap/Depr(3y)40.81%
Cap/Depr(5y)35.34%
Cap/Sales(3y)1.48%
Cap/Sales(5y)1.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.33%
EPS 3Y-11.42%
EPS 5Y25.54%
EPS Q2Q%66.13%
EPS Next Y10.42%
EPS Next 2Y12.22%
EPS Next 3Y37.19%
EPS Next 5Y35.11%
Revenue 1Y (TTM)2.18%
Revenue growth 3Y6.44%
Revenue growth 5Y27.97%
Sales Q2Q%1.17%
Revenue Next Year-0.17%
Revenue Next 2Y1.76%
Revenue Next 3Y2.93%
Revenue Next 5Y6.82%
EBIT growth 1Y1.51%
EBIT growth 3Y-6.54%
EBIT growth 5Y33.76%
EBIT Next Year113.78%
EBIT Next 3Y34.56%
EBIT Next 5Y22.56%
FCF growth 1Y6.52%
FCF growth 3Y4.49%
FCF growth 5Y30.17%
OCF growth 1Y6.66%
OCF growth 3Y4.91%
OCF growth 5Y29.46%